HEADER PROTEIN BINDING 26-JAN-10 2KTB TITLE SOLUTION STRUCTURE OF THE SECOND BROMODOMAIN OF HUMAN POLYBROMO IN TITLE 2 COMPLEX WITH AN ACETYLATED PEPTIDE FROM HISTONE 3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: H3_PEPTIDE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: H3(1-20)K14AC; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PROTEIN POLYBROMO-1; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: POLYBROMO BROMDOMAIN 2; COMPND 11 SYNONYM: HPB1, POLYBROMO-1D, BRG1-ASSOCIATED FACTOR 180, BAF180; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 MOL_ID: 2; SOURCE 4 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 5 ORGANISM_COMMON: HUMAN; SOURCE 6 ORGANISM_TAXID: 9606; SOURCE 7 GENE: PB1, PBRM1; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 10 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS BROMODOMAIN, ALTERNATIVE SPLICING, CHROMATIN REGULATOR, DNA-BINDING, KEYWDS 2 NUCLEUS, PHOSPHOPROTEIN, TRANSCRIPTION, TRANSCRIPTION REGULATION, KEYWDS 3 PROTEIN BINDING EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR Z.CHARLOP-POWERS,Q.ZHANG,L.ZENG REVDAT 4 15-NOV-23 2KTB 1 ATOM REVDAT 3 16-MAR-22 2KTB 1 REMARK SEQADV LINK REVDAT 2 19-MAY-10 2KTB 1 JRNL REVDAT 1 12-MAY-10 2KTB 0 JRNL AUTH Z.CHARLOP-POWERS,L.ZENG,Q.ZHANG,M.M.ZHOU JRNL TITL STRUCTURAL INSIGHTS INTO SELECTIVE HISTONE H3 RECOGNITION BY JRNL TITL 2 THE HUMAN POLYBROMO BROMODOMAIN 2. JRNL REF CELL RES. V. 20 529 2010 JRNL REFN ISSN 1001-0602 JRNL PMID 20368734 JRNL DOI 10.1038/CR.2010.43 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA 2.2, CNS 2.2 REMARK 3 AUTHORS : LINGE, J.P. ET AL. (ARIA), BRUNGER, A.T. ET AL. REMARK 3 (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2KTB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JAN-10. REMARK 100 THE DEPOSITION ID IS D_1000101547. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 0.1 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5 MM [U-100% 15N] POLYBROMO REMARK 210 BROMDOMAIN2, 2.5 MM H3 PEPTIDE, REMARK 210 90% H2O/10% D2O; 0.5 MM [U-100% REMARK 210 13C; U-100% 15N] POLYBROMO REMARK 210 BROMDOMAIN2, 2.5 MM H3 PEPTIDE, REMARK 210 90% H2O/10% D2O; 0.8 MM [U-100% REMARK 210 13C; U-100% 15N] POLYBROMO REMARK 210 BROMDOMAIN2, 8 MM H3 PEPTIDE, REMARK 210 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D 1H-13C NOESY; 3D 1H-15N REMARK 210 NOESY; 3D HNCACB; 3D HN(CO)CA; REMARK 210 2D 1H-15N HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : DRX; AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, NMRVIEW REMARK 210 METHOD USED : SIMULATED ANNEALING, TORSION REMARK 210 ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLN A 5 -159.75 -82.40 REMARK 500 1 THR A 6 -164.10 51.78 REMARK 500 1 ALA A 7 87.23 60.18 REMARK 500 1 ARG A 8 108.94 -160.57 REMARK 500 1 SER A 10 -69.95 -120.84 REMARK 500 1 THR A 11 -85.40 59.66 REMARK 500 1 ALY A 14 -24.14 -163.43 REMARK 500 1 PRO A 16 174.58 -55.29 REMARK 500 1 ARG A 17 -21.41 74.85 REMARK 500 1 THR B 174 -57.23 -138.15 REMARK 500 1 GLU B 175 -142.90 51.89 REMARK 500 1 SER B 177 -96.73 48.27 REMARK 500 1 LEU B 203 129.26 -37.74 REMARK 500 1 PRO B 212 -105.08 -44.87 REMARK 500 1 VAL B 215 -35.81 -149.04 REMARK 500 1 ILE B 228 120.08 177.27 REMARK 500 1 TYR B 242 -54.57 -125.14 REMARK 500 1 LYS B 243 -4.40 66.62 REMARK 500 1 MET B 292 -67.77 -129.72 REMARK 500 2 LYS A 4 -177.96 59.22 REMARK 500 2 THR A 6 -70.94 -90.31 REMARK 500 2 ALA A 7 160.67 63.88 REMARK 500 2 THR A 11 79.21 -105.95 REMARK 500 2 ALY A 14 -164.31 -123.77 REMARK 500 2 ALA A 15 141.83 62.17 REMARK 500 2 ARG A 17 77.33 -157.70 REMARK 500 2 LYS A 18 -172.44 57.63 REMARK 500 2 SER B 177 -93.15 57.48 REMARK 500 2 LEU B 203 126.97 -31.98 REMARK 500 2 PRO B 212 -153.07 -60.05 REMARK 500 2 LYS B 214 -0.17 -49.97 REMARK 500 2 ILE B 228 122.22 177.37 REMARK 500 2 ASN B 239 21.01 -78.35 REMARK 500 2 MET B 292 -73.45 -83.52 REMARK 500 3 LYS A 4 -32.18 -135.74 REMARK 500 3 GLN A 5 97.40 56.01 REMARK 500 3 ALA A 7 -175.38 -67.92 REMARK 500 3 LYS A 9 -79.23 -99.94 REMARK 500 3 ALY A 14 -96.44 -133.81 REMARK 500 3 PRO A 16 95.47 -35.92 REMARK 500 3 ARG A 17 87.00 -153.84 REMARK 500 3 GLU B 175 -2.27 -145.61 REMARK 500 3 SER B 177 -92.66 58.47 REMARK 500 3 PRO B 199 -8.16 -53.51 REMARK 500 3 LEU B 203 123.27 -36.63 REMARK 500 3 PRO B 212 -167.51 -68.67 REMARK 500 3 LYS B 214 -38.42 75.36 REMARK 500 3 ILE B 228 120.75 -174.07 REMARK 500 4 ARG A 2 157.68 63.08 REMARK 500 4 THR A 3 89.30 56.95 REMARK 500 REMARK 500 THIS ENTRY HAS 324 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 2KTB B 174 293 UNP Q86U86 PB1_HUMAN 174 293 DBREF 2KTB A 1 20 PDB 2KTB 2KTB 1 20 SEQADV 2KTB SER B 173 UNP Q86U86 EXPRESSION TAG SEQRES 1 A 20 ALA ARG THR LYS GLN THR ALA ARG LYS SER THR GLY GLY SEQRES 2 A 20 ALY ALA PRO ARG LYS GLN LEU SEQRES 1 B 121 SER THR GLU GLY SER SER PRO ALA TYR LEU LYS GLU ILE SEQRES 2 B 121 LEU GLU GLN LEU LEU GLU ALA ILE VAL VAL ALA THR ASN SEQRES 3 B 121 PRO SER GLY ARG LEU ILE SER GLU LEU PHE GLN LYS LEU SEQRES 4 B 121 PRO SER LYS VAL GLN TYR PRO ASP TYR TYR ALA ILE ILE SEQRES 5 B 121 LYS GLU PRO ILE ASP LEU LYS THR ILE ALA GLN ARG ILE SEQRES 6 B 121 GLN ASN GLY SER TYR LYS SER ILE HIS ALA MET ALA LYS SEQRES 7 B 121 ASP ILE ASP LEU LEU ALA LYS ASN ALA LYS THR TYR ASN SEQRES 8 B 121 GLU PRO GLY SER GLN VAL PHE LYS ASP ALA ASN SER ILE SEQRES 9 B 121 LYS LYS ILE PHE TYR MET LYS LYS ALA GLU ILE GLU HIS SEQRES 10 B 121 HIS GLU MET ALA MODRES 2KTB ALY A 14 LYS N(6)-ACETYLLYSINE HET ALY A 14 26 HETNAM ALY N(6)-ACETYLLYSINE FORMUL 1 ALY C8 H16 N2 O3 HELIX 1 1 SER B 178 ALA B 196 1 19 HELIX 2 2 ILE B 204 GLN B 209 5 6 HELIX 3 3 TYR B 217 ILE B 224 1 8 HELIX 4 4 ASP B 229 ASN B 239 1 11 HELIX 5 5 SER B 244 ASN B 263 1 20 HELIX 6 6 SER B 267 GLU B 291 1 25 LINK C GLY A 13 N ALY A 14 1555 1555 1.33 LINK C ALY A 14 N ALA A 15 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1